NCT01069692 - Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients | Biotech Hunter

Enrollment

115

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

October 31, 2010

Conditions

HyperphosphatemiaChronic Kidney Disease

Interventions

DRUG

SBR759A

SBR759A 6g daily

DRUG

SBR759A

Placebo Comparator 0g daily

DRUG

SBR759A

SBR759A 3g daily

DRUG

SBR759A

9g daily

DRUG

SBR759A

12g daily

Trial Locations (9)

Novartis Investigative Site, Jette

Novartis Investigative Site, Liège

Novartis Investigative Site, Roeselare

Novartis Investigative Site, Lecco

Novartis Investigative Site, Brescia

Novartis Investigative Site, Pavia

Novartis Investigative Site, Siena

Novartis Investigator Site, Lucca

Novartis Investigative Site, Napoli